EUVIMEDEUVIMED entdecken
Crossref

Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma

Christina Laschinsky, Sarah Theurer, Thomas Herold, Josefine Rawitzer, Frank Weber, Ken Herrmann, Tim Brandenburg, Dagmar Führer-Sakel, Wolfgang P Fendler, Manuel Weber

Journal of Nuclear Medicine · 2023-12 · 64 (12) · 1865-1868

DOI: 10.2967/jnumed.123.266044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 26.10.2023. Verfasst von Christina Laschinsky und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital Essen, Essen, Germany; christina.laschinsky@uk-essen.de. Hauptthemen laut MEDLINE: Telomerase, Carcinoma, Papillary, Thyroid Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The onset of radioiodine-refractory thyroid carcinoma (RR-TC) is a negative predictor of survival and has been linked to the presence of BRAFV600E mutations in papillary thyroid cancer. We aimed to identify further genetic alterations associated with RR-TC.

Methods

We included 38 patients with papillary thyroid cancer who underwent radioiodine imaging and 18F-FDG PET/CT after total thyroidectomy. The molecular profile was assessed by next-generation sequencing. The time to the onset of RR-TC for different genetic alterations was compared using the log-rank test.

Results

The median onset to RR-TC was 0.7 and 19.8 mo in patients with and without, respectively, telomerase reverse transcriptase promoter mutations (P = 0.02) and 1.7 and 19.8 mo in patients with and without, respectively, a tumor protein 53 mutation (P < 0.01). This association was not observed for BRAFV600E mutations (P = 0.49).

Conclusion

Our data show a significant association between the onset of RR-TC and mutations in telomerase reverse transcriptase promoter and tumor protein 53, indicating the need for a more extensive diagnostic workup in these patients. Certain genetic changes put patients with thyroid cancer at risk of developing cancer spread that does not respond to radioiodine therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseCarcinoma, PapillaryThyroid NeoplasmsHumansThyroid Cancer, PapillaryIodine RadioisotopesProto-Oncogene Proteins B-rafPositron Emission Tomography Computed TomographyBiomarkersMutation

Stichwörter der Autor:innen

TP53molecular alterationsmolecular imagingpapillary thyroid cancerradioiodine refractorinessradionuclide therapy

Substanzen

Iodine RadioisotopesTelomeraseProto-Oncogene Proteins B-rafBiomarkers

Autor:innen und Institutionen

  • Department of Nuclear Medicine, University Hospital Essen, Essen, Germany; christina.laschinsky@uk-essen.de.
  • German Cancer Consortium, Partner Site Essen, Essen, Germany.
  • Institute of Pathology, University Hospital Essen, Essen, Germany.
  • Department of Surgery, Section of Endocrine Surgery, Essen University Hospital, Essen, Germany; and.
  • Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
  • Department of Endocrinology, Diabetes, and Metabolism, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Zitieren

APA

Laschinsky, C., Theurer, S., Herold, T., Rawitzer, J., Weber, F., Herrmann, K., Brandenburg, T., Führer-Sakel, D., Fendler, W. P., & Weber, M. (2023). Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma. Journal of Nuclear Medicine, 64(12), 1865-1868. https://doi.org/10.2967/jnumed.123.266044

Vancouver

Laschinsky C, Theurer S, Herold T, Rawitzer J, Weber F, Herrmann K, et al. Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma. Journal of Nuclear Medicine. 2023;64(12):1865-1868. doi:10.2967/jnumed.123.266044

BibTeX
@article{Laschinsky2023,
  author = {Laschinsky, Christina and Theurer, Sarah and Herold, Thomas and Rawitzer, Josefine and Weber, Frank and Herrmann, Ken and Brandenburg, Tim and Führer-Sakel, Dagmar and Fendler, Wolfgang P and Weber, Manuel},
  title = {Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  volume = {64},
  number = {12},
  pages = {1865--1868},
  doi = {10.2967/jnumed.123.266044}
}
Kostenlos starten →